# Glibenclamide in Aneurysmatic Subarachnoid Hemorrhage

> **NCT03569540** · PHASE4 · UNKNOWN · sponsor: **University of Sao Paulo General Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Subarachnoid Hemorrhage, Aneurysmal

## Interventions

- **DRUG:** Glibenclamide
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03569540
- **Lead sponsor:** University of Sao Paulo General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-03
- **Primary completion:** 2019-07-01
- **Final completion:** 2019-12-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2018-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03569540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03569540, "Glibenclamide in Aneurysmatic Subarachnoid Hemorrhage". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03569540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*